trending Market Intelligence /marketintelligence/en/news-insights/trending/_brojezzflwkangslvwldq2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Novelion seeking approval for leptin drug in EU

L.K. Bennett: Bankruptcy Case Study

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry


Novelion seeking approval for leptin drug in EU

Novelion Therapeutics Inc. is seeking approval for Metreleptin in Europe.

The company filed an application with the European Medicines Agency to market Metreleptin as therapy for leptin deficiency in patients with lipodystrophy, the loss of fat from a part of the body.

Metreleptin was orphan-drug designated in the EU in July 2012.